A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury

Neuroscience Letters

Volumn 432, Issue 1, 2008, Pages 13-18

  Liu, Wanhong ^a   Liu, Zhongchun ^a   Liu, Li ^c   Xiao, Zheman ^a   Cao, Xiongbin ^d   Cao, Zhijian ^b   Xue, Lu ^b   Miao, Lixia ^a   He, Xiaohua ^a   Li, Wenxin ^b  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Henan Institute of Metrology   (China)

^d Huangshi Central Hospital   (China)

Author keywords

GAD; Gene therapy; HFV; Neuropathic pain

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 67; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENE TRANSFER; MALE; NERVE CELL; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SIMIAN FOAMY VIRUS; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; SPINAL GANGLION;

ANIMALS; BEHAVIOR, ANIMAL; GAMMA-AMINOBUTYRIC ACID; GANGLIA, SPINAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLUTAMATE DECARBOXYLASE; HYPERALGESIA; INJECTIONS, SUBCUTANEOUS; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; SPUMAVIRUS;

EID: 38749153918     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.11.054     Document Type: Article

References (20)

1. Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotraum. 12 (1995) 1-21
2. Bourdelais A., and Kalivas P.W. High sensitivity HPLC assay for GABA in brain dialysis studies. J. Neurosci. Method. 29 (1991) 115-121
3. Cao X.B., Liu W.H., Xue L., Cao Z.J., Sheng J.Q., Liu H., He X.H., and Li W.X. Construction of HFV vector-mediated GAD gene and its application to a Parkinson's disease rat model. J. Wuhan Univ. (Nat. Sci. Ed.) 52 (2006) 202-206
4. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Method. 53 (1994) 55-63
5. Goss J.R. The therapeutic potential of gene transfer for the treatment of peripheral neuropathies. Expert Rev. Mol. Med. 9 (2007) 1-20
6. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
7. Li Z., Yang P., Liu H., and Li W.X. Construction of replication-defective human foamy virus vector directing expression of foreign genes. Virologica Sinica 17 (2002) 114-118
8. Li Z., Yang P., Liu H., and Li W.X. A new indicator cell line to monitor human foamy virus infection and stability in vitro. Intervirology 45 (2002) 79-84
9. Liu W., He X., Cao Z., Sheng J., Liu H., Li Z., and Li W. Efficient therapeutic gene expression in cultured rat hippocampal neurons mediated by human foamy virus vectors: a potential for the treatment of neurological diseases. Intervirology 48 (2005) 329-335
10. Liu W., Liu Z., Cao X., Cao Z., Xue L., Zhu F., He X., and Li W. Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes. Mol. Ther. 15 (2007) 1834-L1841
11. Martin D.L., Martin S.B., Wu S.J., and Espina N. Cofactor interactions and the regulation of glutamate decarboxylase activity. Neurochem. Res. 16 (1991) 243-249
12. Mergia A., Chari S., Kolson D.L., Goodenow M.M., and Ciccarone T. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs. Virology 280 (2001) 243-252
13. Moore K.A., Kohno T., Karchewski L.A., Scholz J., Baba H., and Woolf C.J. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J. Neurosci. 22 (2002) 6724-6731
14. Saib A., Puvion-Dutilleul F., Schmid M., and Peries J. The HD: nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J. Virol. 71 (1997) 1155-1161
15. Sindrup S.H., and Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83 (1999) 389-400
16. Soghomonian J.J., and Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol. Sci. 19 (1998) 500-505
17. Trobridge G.D., Miller D.G., Jacobs M.A., Allen J.M., Kiem H.P., Kaul R., and Russell D.W. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. USA 103 (2006) 1498-1503
18. Yezierski R.P. Pain following spinal cord injury: the clinical problem and experimental studies. Pain 68 (1996) 185-194
19. Zhang L., Li Z., Liu W.H., Liu H., He X.H., and Li W.X. Construction of replication-defective virus vector helper plasmid pΔGP and co-transfection to HIC cell. J. Wuhan Univ. (Nat. Sci. Ed.) 49 (2003) 756-760
20. Zhang S., Tang J.S., Yuan B., and Jia H. Involvement of the frontal ventrolateral orbital cortex in descending inhibition of nociception mediated by the periaqueductal gray in rats. Neurosci. Lett. 224 (1997) 142-146